These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Elevated Lipoprotein(a) and Risk of Atrial Fibrillation: An Observational and Mendelian Randomization Study. Mohammadi-Shemirani P; Chong M; Narula S; Perrot N; Conen D; Roberts JD; Thériault S; Bossé Y; Lanktree MB; Pigeyre M; Paré G J Am Coll Cardiol; 2022 Apr; 79(16):1579-1590. PubMed ID: 35450575 [TBL] [Abstract][Full Text] [Related]
5. Genetic Variation in LPA, Calcific Aortic Valve Stenosis in Patients Undergoing Cardiac Surgery, and Familial Risk of Aortic Valve Microcalcification. Perrot N; Thériault S; Dina C; Chen HY; Boekholdt SM; Rigade S; Després AA; Poulin A; Capoulade R; Le Tourneau T; Messika-Zeitoun D; Trottier M; Tessier M; Guimond J; Nadeau M; Engert JC; Khaw KT; Wareham NJ; Dweck MR; Mathieu P; Pibarot P; Schott JJ; Thanassoulis G; Clavel MA; Bossé Y; Arsenault BJ JAMA Cardiol; 2019 Jul; 4(7):620-627. PubMed ID: 31141105 [TBL] [Abstract][Full Text] [Related]
6. Estimation of the Required Lipoprotein(a)-Lowering Therapeutic Effect Size for Reduction in Coronary Heart Disease Outcomes: A Mendelian Randomization Analysis. Lamina C; Kronenberg F; JAMA Cardiol; 2019 Jun; 4(6):575-579. PubMed ID: 31017618 [TBL] [Abstract][Full Text] [Related]
7. Causal associations between insulin and Lp(a) levels in Caucasian population: a Mendelian randomization study. Lejawa M; Goławski M; Fronczek M; Osadnik T; Paneni F; Ruscica M; Pawlas N; Lisik M; Banach M Cardiovasc Diabetol; 2024 Aug; 23(1):316. PubMed ID: 39210428 [TBL] [Abstract][Full Text] [Related]
8. The association between circulating lipoprotein(a) and type 2 diabetes: is it causal? Ye Z; Haycock PC; Gurdasani D; Pomilla C; Boekholdt SM; Tsimikas S; Khaw KT; Wareham NJ; Sandhu MS; Forouhi NG Diabetes; 2014 Jan; 63(1):332-342. PubMed ID: 24089516 [TBL] [Abstract][Full Text] [Related]
9. Association of Lipoprotein (a) variants with risk of cardiovascular disease: a Mendelian randomization study. Xia J; Guo C; Liu K; Xie Y; Cao H; Peng W; Sun Y; Liu X; Li B; Zhang L Lipids Health Dis; 2021 Jun; 20(1):57. PubMed ID: 34074296 [TBL] [Abstract][Full Text] [Related]
10. A data-driven approach for studying the role of body mass in multiple diseases: a phenome-wide registry-based case-control study in the UK Biobank. Hyppönen E; Mulugeta A; Zhou A; Santhanakrishnan VK Lancet Digit Health; 2019 Jul; 1(3):e116-e126. PubMed ID: 33323262 [TBL] [Abstract][Full Text] [Related]
11. Causal Effect of Lp(a) [Lipoprotein(a)] Level on Ischemic Stroke and Alzheimer Disease: A Mendelian Randomization Study. Pan Y; Li H; Wang Y; Meng X; Wang Y Stroke; 2019 Dec; 50(12):3532-3539. PubMed ID: 31597550 [TBL] [Abstract][Full Text] [Related]
12. Genetic Association of Waist-to-Hip Ratio With Cardiometabolic Traits, Type 2 Diabetes, and Coronary Heart Disease. Emdin CA; Khera AV; Natarajan P; Klarin D; Zekavat SM; Hsiao AJ; Kathiresan S JAMA; 2017 Feb; 317(6):626-634. PubMed ID: 28196256 [TBL] [Abstract][Full Text] [Related]
13. Circulating lipoprotein(a) levels and health outcomes: Phenome-wide Mendelian randomization and disease-trajectory analyses. Larsson SC; Wang L; Li X; Jiang F; Chen X; Mantzoros CS Metabolism; 2022 Dec; 137():155347. PubMed ID: 36396079 [TBL] [Abstract][Full Text] [Related]
14. Associations of Genetically Predicted Lp(a) (Lipoprotein [a]) Levels With Cardiovascular Traits in Individuals of European and African Ancestry. Satterfield BA; Dikilitas O; Safarova MS; Clarke SL; Tcheandjieu C; Zhu X; Bastarache L; Larson EB; Justice AE; Shang N; Rosenthal EA; Shah AS; Namjou-Khales B; Urbina EM; Wei WQ; Feng Q; Jarvik GP; Hebbring SJ; de Andrade M; Manolio TA; Assimes TL; Kullo IJ Circ Genom Precis Med; 2021 Aug; 14(4):e003354. PubMed ID: 34282949 [TBL] [Abstract][Full Text] [Related]
15. Genetically Proxied Diurnal Preference, Sleep Timing, and Risk of Major Depressive Disorder. Daghlas I; Lane JM; Saxena R; Vetter C JAMA Psychiatry; 2021 Aug; 78(8):903-910. PubMed ID: 34037671 [TBL] [Abstract][Full Text] [Related]
16. Association of Body Mass Index With Cardiometabolic Disease in the UK Biobank: A Mendelian Randomization Study. Lyall DM; Celis-Morales C; Ward J; Iliodromiti S; Anderson JJ; Gill JMR; Smith DJ; Ntuk UE; Mackay DF; Holmes MV; Sattar N; Pell JP JAMA Cardiol; 2017 Aug; 2(8):882-889. PubMed ID: 28678979 [TBL] [Abstract][Full Text] [Related]
17. Conventional and Mendelian randomization analyses suggest no association between lipoprotein(a) and early atherosclerosis: the Young Finns Study. Kivimäki M; Magnussen CG; Juonala M; Kähönen M; Kettunen J; Loo BM; Lehtimäki T; Viikari J; Raitakari OT Int J Epidemiol; 2011 Apr; 40(2):470-8. PubMed ID: 21078622 [TBL] [Abstract][Full Text] [Related]
19. Association between lipoprotein(a) level and type 2 diabetes: no evidence for a causal role of lipoprotein(a) and insulin. Buchmann N; Scholz M; Lill CM; Burkhardt R; Eckardt R; Norman K; Loeffler M; Bertram L; Thiery J; Steinhagen-Thiessen E; Demuth I Acta Diabetol; 2017 Nov; 54(11):1031-1038. PubMed ID: 28866807 [TBL] [Abstract][Full Text] [Related]
20. Genome-Wide Association Study Highlights Hoekstra M; Chen HY; Rong J; Dufresne L; Yao J; Guo X; Tsai MY; Tsimikas S; Post WS; Vasan RS; Rotter JI; Larson MG; Thanassoulis G; Engert JC Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):458-464. PubMed ID: 33115273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]